Thank you for choosing ACROBiosystems. Would you rate our product and service？
Participate in the survey and you will have the chance to win the gift of your choice!
Thank you for choosing ACROBiosystems. Would you rate our product and service？
Participate in the survey and you will have the chance to win the gift of your choice!
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| IFB-H5253 | Human | Human IFN-alpha 2b (K46R) Protein, Fc Tag (MALS verified) |  |
|
|
Loaded Human IFNAR2, His Tag (Cat. No. IF2-H5224) on HIS1K Biosensor, can bind Human IFN-alpha 2b (K46R), Fc Tag (Cat. No. IFB-H5253) with an affinity constant of 0.329 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Interferon alfa-2a biosimilar (BioGeneric Pharma) | Approved | Biogeneric | Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Hairy Cell; Hepatitis C; Sarcoma, Kaposi | Details | ||||||
| Interferon alfa-2b biosimilar (Virchow Group) | Approved | Virchow Group | Hepatitis B; Hepatitis C | Details | ||||||
| Interferon alfa-2b biosimilar (BioGeneric) | Approved | Biogeneric | Egypt | Hepatitis B; Hepatitis C; Neoplasms | Biogeneric | 2013-05-01 | Neoplasms; Hepatitis B; Hepatitis C | Details | ||
| Recombinant Human Interferon α2a (Wuhan Wei'Ao) | Approved | Wuhan Wei'Ao Pharmaceutical Co Ltd | 奥平 | Mainland China | Virus Diseases | Wuhan Wei'Ao Pharmaceutical Co Ltd | 1998-01-01 | Virus Diseases | Details | |
| Interferon alfa-2b (Changchun Heber) | rHuIFNa-2b | Approved | Changchun Heber Biological Technology Co Ltd | Mainland China | Virus Diseases; Neoplasms | Changchun Heber Biological Technology Co Ltd | 2006-01-01 | Virus Diseases; Neoplasms | Details | |
| Peginterferon alpha-2b biosimilar (Zydus Cadila) | Approved | Zydus Cadila | Japan | Condylomata Acuminata; Hepatitis B; Hepatitis C | Zydus Cadila | 2014-01-01 | Hepatitis B; Hepatitis C; Condylomata Acuminata | Details | ||
| Interferon-alpha 2 (CJ Corporation) | Approved | Cj | Leukemia, Hairy Cell; Carcinoma, Renal Cell; Multiple Myeloma; Hepatitis B; Hepatitis C; Sarcoma, Kaposi; Melanoma | Details | ||||||
| Interferon alfa-2b biosimilar (PT Kalbe) | Approved | Kalbe Farma | Kalferon | Hepatitis B; Hepatitis C; Lymphoma, Non-Hodgkin; Melanoma | Details | |||||
| Peginterferon alfa-2a (Pooyesh Darou Pharmaceuticals) | Approved | Pooyesh Darou | Iran | Hepatitis B; Hepatitis C | Pooyesh Darou | 2008-01-01 | Hepatitis B; Hepatitis C | Details | ||
| Recombinant interferon alpha-2a (Changchun ChangSheng Gene Pharmaceutical) | Approved | Changchun Changsheng Gene Pharmaceutical Stock Co Ltd | 忆林, Yilin | Mainland China | Condylomata Acuminata; Herpes Simplex | Changchun Changsheng Gene Pharmaceutical Stock Co Ltd | 2004-09-14 | Herpes Simplex; Condylomata Acuminata | Details | |
| Interferon alpha-2b biosimilar (PharmBiotek) | Approved | Pharmbiotek | Laferon, Laferonum | Ukraine | Pharmbiotek | 2004-01-01 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Ovarian Neoplasms; Bone Marrow Neoplasms; Leukemia, Hairy Cell; Carcinoma, Renal Cell; Sepsis; Papillomavirus Infections; Herpesviridae Infections; Urinary Bladder Neoplasms; Multiple Sclerosis; Hepatitis B; Chlamydia Infections; Breast Neoplasms; Lymphoma, Non-Hodgkin; Sarcoma, Kaposi; Melanoma | Details | ||
| Recombinant human interferon alpha-1b (Beijing Tri-Prime Genetic Engineering) | Approved | Beijing Tri-Prime Gene Pharmaceutical Co Ltd | 运德素, YunDeSu | Mainland China | Virus Diseases; Neoplasms | Beijing Tri-Prime Gene Pharmaceutical Co Ltd | 1999-01-01 | Pneumonia; Virus Diseases; Neoplasms; Bronchiolitis; Respiratory Syncytial Virus Infections | Details | |
| Interferon alfa-2b biosimilar (Pooyesh Darou Pharmaceuticals) | Approved | Pooyesh Darou | PDferon-B | Iran | Hepatitis B; Hepatitis C; Leukemia, Hairy Cell; Lymphoma, Follicular; Melanoma; Multiple Myeloma; Malignant Carcinoid Syndrome | Pooyesh Darou | 2012-09-01 | Leukemia, Hairy Cell; Malignant Carcinoid Syndrome; Multiple Myeloma; Hepatitis B; Lymphoma, Follicular; Hepatitis C; Melanoma | Details | |
| Interferon alfa-2b biosimilar (CIGB/Heber Biotec) | Approved | Center For Genetic Engineering And Biotechnology | Inrec, Heberon Alfa R | Uruguay | Virus Diseases | Heber Biotec | 2000-12-01 | Virus Diseases | Details | |
| Recombinant interferon alpha-2a (Shanghai Tenry) | Approved | Shanghai Tenry Pharmaceutical Co Ltd | 万复洛 | Mainland China | Neoplasms; Virus Diseases | Shanghai Tenry Pharmaceutical Co Ltd | 2000-01-01 | Neoplasms; Virus Diseases | Details | |
| Interferon alfa-2b (Anhui Anke Biotechnology) | rHuIFNa-2b | Approved | Anhui Anke Biotechnology (Group) Co Ltd | 安达芬 | Mainland China | Condylomata Acuminata; Hepatitis B; Herpes Simplex; Herpes Zoster; Herpes Zoster Ophthalmicus; Papillomavirus Infections; Hepatitis C; Leukemia, Hairy Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Uterine Cervical Erosion | Anhui Anke Biotechnology (Group) Co Ltd | 1997-01-01 | Herpes Simplex; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Herpes Zoster Ophthalmicus; Leukemia, Hairy Cell; Papillomavirus Infections; Herpangina; Uterine Cervical Erosion; Hepatitis B; Hepatitis C; Condylomata Acuminata; Herpes Zoster | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Peginterferon alfa-2a follow-on biologic (Biocad) | BCD-081 | Clinical | Biocad | Hepatitis C | Details |
| GSK-2245035 | GSK-2245035 | Phase 2 Clinical | Glaxosmithkline Plc | Rhinitis, Allergic, Seasonal; Rhinitis, Allergic; Asthma; Rhinitis | Details |
| SFR-9216 | SFR-9216 | Phase 1 Clinical | Tianjin Puying Biotechnology Co Ltd | Hepatitis B | Details |
| Q101-pegylated recombinant human interferon alpha-2a (Shijiazhuang Zhongqi Pharmaceutical) | Q-101 (Shijiazhuang Zhongqi Pharmaceutical); PEG-IFN-α-2a | Phase 1 Clinical | Cspc Pharmaceutical Technology (Shijiazhuang) Co Ltd | Hepatitis B | Details |
| Recombinant human serum albumin-interferon-alpha-2a fusion protein (Qilu Pharmaceutical) | Phase 1 Clinical | Qilu Pharmaceutical Co Ltd, Institute Of Bioengineering Chinese Academy Of Military Medical Sciences | Hepatitis B, Chronic; Hepatitis B | Details |
This web search service is supported by Google Inc.
A-Z